320 related articles for article (PubMed ID: 31199069)
1. 4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement.
Zheng Z; Ma T; Guo H; Kim KS; Kim KT; Bi L; Zhang Z; Cai L
J Cell Mol Med; 2019 Aug; 23(8):5771-5781. PubMed ID: 31199069
[TBL] [Abstract][Full Text] [Related]
2. 4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress.
Ma T; Zheng Z; Guo H; Lian X; Rane MJ; Cai L; Kim KS; Kim KT; Zhang Z; Bi L
Toxicol Appl Pharmacol; 2019 May; 370():93-105. PubMed ID: 30876865
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
Sun Y; Zhou S; Guo H; Zhang J; Ma T; Zheng Y; Zhang Z; Cai L
Metabolism; 2020 Jan; 102():154002. PubMed ID: 31706979
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function.
Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L
Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670
[TBL] [Abstract][Full Text] [Related]
6. The magnolia bioactive constituent 4-O-methylhonokiol protects against high-fat diet-induced obesity and systemic insulin resistance in mice.
Zhang Z; Chen J; Jiang X; Wang J; Yan X; Zheng Y; Conklin DJ; Kim KS; Kim KH; Tan Y; Kim YH; Cai L
Oxid Med Cell Longev; 2014; 2014():965954. PubMed ID: 24991305
[TBL] [Abstract][Full Text] [Related]
7. Magnolia bioactive constituent 4-O-methylhonokiol prevents the impairment of cardiac insulin signaling and the cardiac pathogenesis in high-fat diet-induced obese mice.
Zhang Z; Chen J; Zhou S; Wang S; Cai X; Conklin DJ; Kim KS; Kim KH; Tan Y; Zheng Y; Kim YH; Cai L
Int J Biol Sci; 2015; 11(8):879-91. PubMed ID: 26157343
[TBL] [Abstract][Full Text] [Related]
8. Si-Miao-Yong-An decoction preserves cardiac function and regulates GLC/AMPK/NF-κB and GLC/PPARα/PGC-1α pathways in diabetic mice.
Li L; Chen X; Su C; Wang Q; Li R; Jiao W; Luo H; Tian Y; Tang J; Li X; Liu B; Wang W; Zhang D; Guo S
Biomed Pharmacother; 2020 Dec; 132():110817. PubMed ID: 33068937
[TBL] [Abstract][Full Text] [Related]
9. Cinacalcet as a surrogate therapy for diabetic cardiomyopathy in rats through AMPK-mediated promotion of mitochondrial and autophagic function.
Elrashidy RA; Ibrahim SE
Toxicol Appl Pharmacol; 2021 Jun; 421():115533. PubMed ID: 33848515
[TBL] [Abstract][Full Text] [Related]
10. Tectorigenin protects against cardiac fibrosis in diabetic mice heart via activating the adiponectin receptor 1-mediated AMPK pathway.
Ma YL; Xu M; Cen XF; Qiu HL; Guo YY; Tang QZ
Biomed Pharmacother; 2024 May; 174():116589. PubMed ID: 38636400
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway.
Zhang Z; Wang S; Zhou S; Yan X; Wang Y; Chen J; Mellen N; Kong M; Gu J; Tan Y; Zheng Y; Cai L
J Mol Cell Cardiol; 2014 Dec; 77():42-52. PubMed ID: 25268649
[TBL] [Abstract][Full Text] [Related]
12. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
[TBL] [Abstract][Full Text] [Related]
13. Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway.
Wei H; Bu R; Yang Q; Jia J; Li T; Wang Q; Chen Y
J Diabetes Res; 2019; 2019():8905917. PubMed ID: 31886288
[TBL] [Abstract][Full Text] [Related]
14. Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK-mTOR Interplay.
Chen H; Tran D; Yang HC; Nylander S; Birnbaum Y; Ye Y
Cardiovasc Drugs Ther; 2020 Aug; 34(4):443-461. PubMed ID: 32335797
[TBL] [Abstract][Full Text] [Related]
15. Apocynin attenuates diabetic cardiomyopathy by suppressing ASK1-p38/JNK signaling.
Ding W; Feng H; Li WJ; Liao HH; Zhang N; Zhou ZY; Mou SQ; Lin Z; Xia-He NZ; Xia H; Tang QZ
Eur J Pharmacol; 2021 Oct; 909():174402. PubMed ID: 34348125
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: Activation of the AMPK/Nrf2 pathway.
Xu C; Xia L; Xu D; Liu Y; Jin P; Zhai M; Mao Y; Wang Y; Wen A; Yang J; Yang L
J Cell Mol Med; 2024 Jan; 28(2):e18055. PubMed ID: 38113341
[TBL] [Abstract][Full Text] [Related]
17. Diabetic cardiomyopathy - Zinc preventive and therapeutic potentials by its anti-oxidative stress and sensitizing insulin signaling pathways.
Cai L; Tan Y; Watson S; Wintergerst K
Toxicol Appl Pharmacol; 2023 Oct; 477():116694. PubMed ID: 37739320
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart.
Yang G; Zhang Q; Dong C; Hou G; Li J; Jiang X; Xin Y
J Cell Physiol; 2024 Feb; 239(2):e31149. PubMed ID: 38308838
[TBL] [Abstract][Full Text] [Related]
19. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.
Tian J; Zhang M; Suo M; Liu D; Wang X; Liu M; Pan J; Jin T; An F
J Cell Mol Med; 2021 Aug; 25(16):7642-7659. PubMed ID: 34169635
[TBL] [Abstract][Full Text] [Related]
20. Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
Chang W; Li K; Guan F; Yao F; Yu Y; Zhang M; Hatch GM; Chen L
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):486-94. PubMed ID: 26846272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
